Advancing Hematopoietic Stem Cell Transplantation (HSCT) in Africa: A Pathway to Curing Hematological Disorders

推进非洲造血干细胞移植(HSCT):治愈血液疾病的途径

阅读:1

Abstract

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) offers a curative option for numerous hematological disorders, notably sickle cell disease and thalassemia, which are highly prevalent in Africa. Despite its potential, access to HSCT remains limited due to infrastructural, economic, and socio-cultural challenges across the continent. METHODS: This review synthesizes current literature and reports on the status of HSCT in Africa, analyzing data from existing transplant centers, national registries, and peer-reviewed studies to assess progress, challenges, and prospects for expanding HSCT services. RESULTS: Out of 54 African countries, only seven perform HSCT, with considerable disparities in the number of procedures, donor availability, and infrastructure. Major barriers include inadequate healthcare infrastructure, limited trained personnel, scarcity of donors, high costs, cultural misconceptions, and poor documentation. Notably, progress has been made in Nigeria, Egypt, Morocco, Tunisia, South Africa, Tanzania and Algeria, but the overall transplant rate remains low. Emerging strategies such as regional collaborations, the development of African-specific donor registries, and technological innovations are being explored to improve access and outcomes. CONCLUSION: While HSCT in Africa is still in its infancy, strategic investments in infrastructure, capacity building, donor registry development, and regional cooperation hold promise for broader access. Integrating technological advances and policy support can accelerate progress, transforming HSCT into a sustainable, accessible curative therapy for hematological disorders across the continent.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。